Literature DB >> 3862109

Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

M T Quinn, S Parthasarathy, D Steinberg.   

Abstract

Cultured rabbit and bovine aortic endothelial cells generated chemotactic activity for mouse resident peritoneal macrophages, demonstrable in the conditioned medium. This chemotactic activity was heat stable and was not extracted into chloroform/methanol. It was inhibited by addition of endothelial cell-modified low density lipoprotein (EC-modified LDL), a form of LDL shown previously to contain peroxidized lipids, increased lysophosphatidylcholine, and partially degraded apoprotein B. The chemotactic activity was also inhibited by LDL previously oxidized in the absence of cells with 5 microM Cu2+. Inhibitory activity was present in the lipid extract of EC-modified LDL but not in that of native LDL, presumably representing peroxidized lipid components. EC-modified LDL also inhibited the chemotactic activity of zymosan-activated serum. Because EC-modified LDL is taken up in part by way of the acetyl-LDL receptor, the effects of acetyl-LDL were tested. Rather than inhibiting chemotaxis, acetyl LDL showed intrinsic positive chemotactic activity as did also fucoidin and polyinosinic acid, both of which also interact with the acetyl-LDL receptor. These studies suggest mechanisms by which macrophages may be recruited into the subendothelial space by endothelial cell-derived chemotactic factors or by natural polyanions structurally related to fucoidin or polyinosinic acid and then become "trapped" there because of the inhibitory effects of peroxidized lipid components in modified forms of LDL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3862109      PMCID: PMC390671          DOI: 10.1073/pnas.82.17.5949

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity.

Authors:  B Bennett; B R Bloom
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

4.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

Authors:  S Parthasarathy; U P Steinbrecher; J Barnett; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  A chemotactic factor for mononuclear leukocytes.

Authors:  R Snyderman; H S Shin; M H Hausman
Journal:  Proc Soc Exp Biol Med       Date:  1971-11

6.  Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta.

Authors:  R G Gerrity; J A Goss; L Soby
Journal:  Arteriosclerosis       Date:  1985 Jan-Feb

7.  LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts.

Authors:  S A Evensen; K S Galdal; E Nilsen
Journal:  Atherosclerosis       Date:  1983-10       Impact factor: 5.162

8.  The release of platelet-activating factor from human endothelial cells in culture.

Authors:  G Camussi; M Aglietta; F Malavasi; C Tetta; W Piacibello; F Sanavio; F Bussolino
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

9.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

Authors:  U P Steinbrecher; S Parthasarathy; D S Leake; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  32 in total

1.  Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL.

Authors:  B P Swets; D A Brouwer; J W Tervaert
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE.

Authors:  Joanne C Conover; Brett A Shook
Journal:  Aging Dis       Date:  2011-01-01       Impact factor: 6.745

Review 3.  Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.

Authors:  S Chatterjee
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

4.  Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  M M Véniant; V Pierotti; D Newland; C M Cham; D A Sanan; R L Walzem; S G Young
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.

Authors:  Shijie Li; Paul Kievit; Anna-Karin Robertson; Ganesh Kolumam; Xiumin Li; Karin von Wachenfeldt; Christine Valfridsson; Sherry Bullens; Ilhem Messaoudi; Lindsay Bader; Kyra J Cowan; Amrita Kamath; Nicholas van Bruggen; Stuart Bunting; Björn Frendéus; Kevin L Grove
Journal:  Mol Metab       Date:  2013-06-11       Impact factor: 7.422

6.  A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.

Authors:  S Parthasarathy; E Wieland; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  In vitro studies of human monocyte migration across endothelium in response to leukotriene B4 and f-Met-Leu-Phe.

Authors:  G Migliorisi; E Folkes; N Pawlowski; E B Cramer
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

8.  Receptor recognition of maleyl-albumin induces chemotaxis in human monocytes.

Authors:  M E Haberland; R R Rasmussen; A M Fogelman
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  The action of defined oxygen-centred free radicals on human low-density lipoprotein.

Authors:  S Bedwell; R T Dean; W Jessup
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

Review 10.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.